Noriyuki Kasahara is a distinguished scientist and professor currently serving as the Chief Scientific Officer at GenVivo, Inc. since August 2025 and as a Professor & Alvera L. Kan Endowed Chair at the University of California, San Francisco since January 2019. Prior to these roles, Kasahara held positions as Chief Scientific Officer at 4D Molecular Therapeutics from January 2024 to July 2025, and as a Visiting Professor at Tokyo Medical and Dental University and several prestigious institutions internationally. With an extensive academic background, Kasahara completed a Doctor of Philosophy in Endocrinology and holds a Doctor of Medicine from Tokyo Medical and Dental University. The career trajectory reflects a strong emphasis on research, education, and leadership within the biomedical sciences.
This person is not in any teams
This person is not in any offices